Rob Maloney: The Power of Partnership in Bleeding Disorders Care
Rob Maloney, Chief Executive Officer of Hemophilia of Georgia, shared a post on LinkedIn:
“Recently I had the honor of sitting down with Dr. Sandra Wong, Dean of Emory’s School of Medicine.
We covered a lot of ground.
How do we keep improving care for our patients with bleeding disorders?
How do we train the next generation of physicians? How do we reach families’ living hours away from specialized care?
Those aren’t small questions. But what struck me most was how naturally the conversation moved.
Because Hemophilia of Georgia and Emory have been walking alongside each other for decades, the trust was already there.
Dean Wong said something I keep coming back to. ‘When we look to improve patient care, great partnerships flourish.’
That’s it.
That’s the whole thing.
The families we serve in Atlanta and in the counties far from it deserve a system that works together on their behalf.
That’s what this partnership has always been about. And I’m grateful it has room to grow.
Thank you, Dean Wong, for your time, your vision, and your commitment to this community.
And to Ashley, who set up the meeting.
None of this starts without the people doing the quiet work behind the scenes.”

Other posts featuring Rob Maloney on Hemostasis Today.
-
Sep 11, 2026, 17:41Khaled Musallam: Earlier Recognition, Better Outcomes in NTDT
-
Sep 11, 2026, 17:29Reyhan Kose Cobanoglu: APS ACTION Registry Study Published in Lupus
-
Sep 11, 2026, 17:14Obi Light Ogbonnia: From Kenya to Global Sickle Cell Advocacy
-
Sep 11, 2026, 17:01EAHAD 2027 Marks 20 Years
-
Sep 11, 2026, 16:54Denise Braendgaard: Reimagining Health Systems Through Collective Action
-
Sep 11, 2026, 16:47Jehad Khamaysa: Budd-Chiari Syndrome as the Initial Presentation of Behçet’s Disease in a 16-Year-Old
-
Sep 11, 2026, 16:44Mostafa Faisal Mohammed Saleh: From HLA Biology to Curative Therapy
-
Sep 11, 2026, 16:38Jim Kaveney: Class I, Level A – Lifestyle is Now the Official Standard in AFib Care
-
Sep 11, 2026, 16:31George Touma: Do We Really Need to Implant Metal in Every High-Bleeding-Risk Patient?